Incidence of SARS-CoV-2 infection and associated risk factors among staff and residents at homeless shelters in King County, Washington: an active surveillance study
- PMID: 37424310
- PMCID: PMC10540173
- DOI: 10.1017/S0950268823001036
Incidence of SARS-CoV-2 infection and associated risk factors among staff and residents at homeless shelters in King County, Washington: an active surveillance study
Abstract
Homeless shelter residents and staff may be at higher risk of SARS-CoV-2 infection. However, SARS-CoV-2 infection estimates in this population have been reliant on cross-sectional or outbreak investigation data. We conducted routine surveillance and outbreak testing in 23 homeless shelters in King County, Washington, to estimate the occurrence of laboratory-confirmed SARS-CoV-2 infection and risk factors during 1 January 2020-31 May 2021. Symptom surveys and nasal swabs were collected for SARS-CoV-2 testing by RT-PCR for residents aged ≥3 months and staff. We collected 12,915 specimens from 2,930 unique participants. We identified 4.74 (95% CI 4.00-5.58) SARS-CoV-2 infections per 100 individuals (residents: 4.96, 95% CI 4.12-5.91; staff: 3.86, 95% CI 2.43-5.79). Most infections were asymptomatic at the time of detection (74%) and detected during routine surveillance (73%). Outbreak testing yielded higher test positivity than routine surveillance (2.7% versus 0.9%). Among those infected, residents were less likely to report symptoms than staff. Participants who were vaccinated against seasonal influenza and were current smokers had lower odds of having an infection detected. Active surveillance that includes SARS-CoV-2 testing of all persons is essential in ascertaining the true burden of SARS-CoV-2 infections among residents and staff of congregate settings.
Keywords: SARS-CoV-2 incidence; Surveillance; cross-sectional study; homeless shelter; infection risk factors; molecular testing.
Conflict of interest statement
Dr. Chu reported consulting with Ellume, Pfizer, the Bill & Melinda Gates Foundation, Glaxo Smith Kline, and Merck. She has received research funding from Gates Ventures and Sanofi Pasteur, and support and reagents from Ellume and Cepheid outside of the submitted work. Dr. Englund reported research support from Merck, AstraZeneca, Pfizer, and GlaxoSmithKline. She is a consultant for Meissa Vaccines, Sanofi Pasteur, and Astra Zeneca.
Figures


Similar articles
-
Characteristics of COVID-19 in Homeless Shelters : A Community-Based Surveillance Study.Ann Intern Med. 2021 Jan;174(1):42-49. doi: 10.7326/M20-3799. Epub 2020 Sep 15. Ann Intern Med. 2021. PMID: 32931328 Free PMC article. Clinical Trial.
-
Factors associated with SARS-CoV-2 positivity in 20 homeless shelters in Toronto, Canada, from April to July 2020: a repeated cross-sectional study.CMAJ Open. 2021 Mar 30;9(1):E302-E308. doi: 10.9778/cmajo.20200253. Print 2021 Jan-Mar. CMAJ Open. 2021. PMID: 33785478 Free PMC article.
-
COVID-19 Outbreak Among Three Affiliated Homeless Service Sites - King County, Washington, 2020.MMWR Morb Mortal Wkly Rep. 2020 May 1;69(17):523-526. doi: 10.15585/mmwr.mm6917e2. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32352954 Free PMC article.
-
SARS-CoV-2 incidence, seroprevalence, and COVID-19 vaccination coverage in the homeless population: a systematic review and meta-analysis.Front Public Health. 2023 Oct 10;11:1044788. doi: 10.3389/fpubh.2023.1044788. eCollection 2023. Front Public Health. 2023. PMID: 37900041 Free PMC article.
-
Universal screening for SARS-CoV-2 infection: a rapid review.Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718. Cochrane Database Syst Rev. 2020. PMID: 33502003 Free PMC article.
Cited by
-
Health and Economic Impact of COVID-19 Surveillance Testing in Seattle Homeless Shelters: A Cost-Effectiveness Analysis.AJPM Focus. 2024 Dec 5;4(2):100307. doi: 10.1016/j.focus.2024.100307. eCollection 2025 Apr. AJPM Focus. 2024. PMID: 40061153 Free PMC article.
-
Respiratory Syncytial Virus, Influenza and SARS-CoV-2 in Homeless People from Urban Shelters: A Systematic Review and Meta-Analysis (2023).Epidemiologia (Basel). 2024 Jan 31;5(1):41-79. doi: 10.3390/epidemiologia5010004. Epidemiologia (Basel). 2024. PMID: 38390917 Free PMC article. Review.
-
Burden of long COVID among adults experiencing sheltered homelessness: a longitudinal cohort study in King County, WA between September 2020-April 2022.BMC Public Health. 2023 Jun 6;23(1):1079. doi: 10.1186/s12889-023-16026-7. BMC Public Health. 2023. PMID: 37277786 Free PMC article.
-
Incidence and factors associated with SARS-CoV-2 infection and re-infection among people experiencing homelessness in Toronto, Canada: A prospective cohort study.PLoS One. 2025 Feb 28;20(2):e0319296. doi: 10.1371/journal.pone.0319296. eCollection 2025. PLoS One. 2025. PMID: 40019892 Free PMC article.
References
-
- Henry M, de Sousa T, Roddey C, Gayen S and Bednar TJ (2020). The 2020 Annual Homeless Assessment Report (AHAR) to Congress [Internet]. Available at https://www.huduser.gov/portal/sites/default/files/pdf/2020-AHAR-Part-1.pdf. Accessed 2 August 2022.
-
- Hsu HE, Ashe EM, Silverstein M, Hofman M, Lange SJ, Razzaghi H, Mishuris RG, Davidoff R, Parker EM, Penman-Aguilar A, Clarke KEN, Goldman A, James TL, Jacobson K, Lasser KE, Xuan Z, Peacock G, Dowling NF, Goodman AB (2020). Race/ethnicity, underlying medical conditions, homelessness, and hospitalization status of adult patients with COVID-19 at an urban safety-net medical center — Boston, Massachusetts, 2020. MMWR Morbidity and Mortality Weekly Report 69(27), 864–869. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous